Media and Investors Resources

Press Release, 23 November 2022

Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH

Press Release, 2 November 2022

Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules

Press Release, 26 October 2022

Adhoc Press Release

Kuros reports 73% increase in MagnetOs sales in first nine months of 2022

Press Release, 19 October 2022

Kuros Biosciences awarded 2022 Spine Technology Award for MagnetOs Flex Matrix by Orthopedics This Week

Press Release, 11 October 2022

Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting

Press Release, 11 October 2022

Kuros Biosciences to present positive clinical data for MagnetOs at NASS 2022 Annual Meeting